RAD-150 is described in the research-chemical marketplace as a long-acting nonsteroidal selective androgen receptor modulator (SARM), related in naming convention to RAD-140 but with a substantially smaller and less…
🔬 Studied for: Emerging SARM Research
💊 Also studied for: Comparative Research Context
🧪 Not FDA-approved — sold strictly for laboratory research
📈 No standardized human dosage established in published literature
RAD-150 is described in the research-chemical marketplace as a long-acting nonsteroidal selective androgen receptor modulator (SARM), related in naming convention to RAD-140 but with a substantially smaller and less independently verified research record.
RAD-150 is marketed as sharing RAD-140's androgen-receptor-selective mechanism with a longer duration of action, though this claim is based primarily on vendor and research-community reporting rather than an independently published pharmacokinetic dataset comparable to RAD-140's.
These are effects RAD-150 has been studied for in available preclinical and early research — not claims about guaranteed outcomes.
RAD-150 is a newer addition to the SARM research-chemical market, and independently published, peer-reviewed data specific to RAD-150 (as opposed to RAD-140) is very limited at this time.
Where RAD-150 is discussed in research contexts, it is typically compared against the better-established RAD-140 dataset rather than supported by its own dedicated clinical or preclinical trial literature.
No dosage of any kind has been clinically validated for RAD-150 in humans. Any protocols circulating in research-community sources are anecdotal and not supported by peer-reviewed trial data.
Compound X does not provide dosing recommendations. RAD-150 is sold for laboratory research use only and is not intended for human consumption.
Because independently published research on RAD-150 specifically is minimal, its human safety profile is essentially uncharacterized. It has never been evaluated in human clinical trials, is not FDA-approved, and no meaningful independent human safety data exists.
No. RAD-150 is not FDA-approved for any indication and is sold strictly as a research chemical, not a medication or dietary supplement.
Emerging SARM Research — RAD-150 is a newer addition to the SARM research-chemical market, and independently published, peer-reviewed data specific to RAD-150 (as opposed to RAD-140) is very limited at this time.
In the US, UK, Canada and Australia, RAD-150 is generally sold labeled "for research use only, not for human consumption." It is not approved as a dietary supplement or medication in any of these countries.
Independently published data specific to RAD-150 is limited; researchers typically cross-reference the broader SARM structure-activity literature indexed on PubMed under "selective androgen receptor modulator."
Compare current prices, purity testing claims and coupon codes across every vendor Compound X tracks.
New guides, vendor comparisons and compound breakdowns every week.